Literature DB >> 29800182

Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery.

Xiaoxi Yao1,2, Bernard J Gersh3, David R Holmes3, Rowlens M Melduni3, Daniel O Johnsrud4, Lindsey R Sangaralingham1, Nilay D Shah1,2,5, Peter A Noseworthy1,3.   

Abstract

Importance: Surgical occlusion of the left atrial appendage (LAAO) may be performed during concurrent cardiac surgery. However, few data exist on the association of LAAO with long-term risk of stroke, and some evidence suggests that this procedure may be associated with subsequent development of atrial fibrillation (AF). Objective: To evaluate the association of surgical LAAO performed during cardiac surgery with risk of stroke, mortality, and development of subsequent AF. Design, Setting, and Participants: Retrospective cohort study using a large US administrative database that contains data from adult patients (≥18 years) with private insurance or Medicare Advantage who underwent coronary artery bypass graft (CABG) or valve surgery between January 1, 2009, and March 30, 2017, with final follow-up on March 31, 2017. One-to-one propensity score matching was used to balance patients on 76 dimensions to compare those with vs without LAAO, stratified by history of prior AF at the time of surgery. Exposures: Surgical LAAO vs no surgical LAAO during cardiac surgery. Main Outcomes and Measures: The primary outcomes were stroke (ie, ischemic stroke or systemic embolism) and all-cause mortality. The secondary outcomes were postoperative AF (AF within 30 days after surgery among patients without prior AF) and long-term AF-related health utilization (event rates of outpatient visits and hospitalizations).
Results: Among 75 782 patients who underwent cardiac surgery (mean age, 66.0 [SD, 11.2] years; 2 2091 [29.2%] women, 25 721 [33.9%] with preexisting AF), 4374 (5.8%) underwent concurrent LAAO, and mean follow-up was 2.1 (SD, 1.9) years. In the 8590 propensity score-matched patients, LAAO was associated with a reduced risk of stroke (1.14 vs 1.59 events per 100 person-years; hazard ratio [HR], 0.73 [95% CI, 0.56-0.96]; P = .03) and mortality (3.01 vs 4.30 events per 100 person-years; HR, 0.71 [95% CI, 0.60-0.84]; P < .001). LAAO was associated with higher rates of AF-related outpatient visits (11.96 vs 10.26 events per person-year; absolute difference, 1.70 [95% CI, 1.60-1.80] events per person-year; rate ratio, 1.17 [95% CI, 1.10-1.24]; P < .001) and hospitalizations (0.36 vs 0.32 event per person-year; absolute difference, 0.04 [95% CI, 0.02-0.06] event per person-year; rate ratio, 1.13 [95% CI, 1.05-1.21]; P = .002). In patients with prior AF (6438/8590 [74.9%]) with vs without LAAO, risk of stroke was 1.11 vs 1.71 events per 100 person-years (HR, 0.68 [95% CI, 0.50-0.92]; P = .01) and risk of mortality was 3.22 vs 4.93 events per 100 person-years (HR, 0.67 [95% CI, 0.56-0.80]; P < .001), respectively. In patients without prior AF (2152/8590 [25.1%]) with vs without LAAO, risk of stroke was 1.23 vs 1.26 events per 100 person-years (HR, 0.95 [95% CI, 0.54-1.68]), risk of mortality was 2.30 vs 2.49 events per 100 person-years (HR, 0.92 [95% CI, 0.61-1.37]), and risk of postoperative AF was 27.7% vs 20.2% events per 100 person-years (HR, 1.46 [95% CI, 1.22-1.73]; P < .001). The interaction term between prior AF and LAAO was not significant (P = .29 for stroke and P = .16 for mortality). Conclusions and Relevance: Among patients undergoing cardiac surgery, concurrent surgical LAAO, compared with no surgical LAAO, was associated with reduced risk of subsequent stroke and all-cause mortality. Further research, including from randomized clinical trials, is needed to more definitively determine the role of surgical LAAO.

Entities:  

Mesh:

Year:  2018        PMID: 29800182      PMCID: PMC6351069          DOI: 10.1001/jama.2018.6024

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  27 in total

Review 1.  Perioperative Biomarkers Predicting Postoperative Atrial Fibrillation Risk After Coronary Artery Bypass Grafting: A Narrative Review.

Authors:  Muhammad S Khan; Kennosuke Yamashita; Vikas Sharma; Ravi Ranjan; Craig H Selzman; Derek J Dosdall
Journal:  J Cardiothorac Vasc Anesth       Date:  2019-09-18       Impact factor: 2.628

Review 2.  [Left atrial appendage closure in non-valvular atrial fibrillation].

Authors:  K G Häusler; U Landmesser
Journal:  Herz       Date:  2019-06       Impact factor: 1.443

3.  Chest radiotherapy after left upper lobectomy may be a risk factor for thrombosis in the pulmonary vein stump.

Authors:  Cheng-Yang Song; Daisuke Kimura; Ikuo Fukuda; Fumiyasu Tsushima; Takehiro Sakai; Takao Tsushima
Journal:  J Cardiothorac Surg       Date:  2022-06-13       Impact factor: 1.522

4.  Association of metabolic acidosis with fractures, falls, protein-calorie malnutrition and failure to thrive in patients with chronic kidney disease.

Authors:  Vandana Mathur; Nancy L Reaven; Susan E Funk; Reid Whitlock; Thomas W Ferguson; David Collister; Navdeep Tangri
Journal:  Clin Kidney J       Date:  2022-03-04

5.  Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice.

Authors:  Peter A Noseworthy; Holly K Van Houten; Bernard J Gersh; Douglas L Packer; Paul A Friedman; Nilay D Shah; Shannon M Dunlay; Konstantinos C Siontis; Jonathan P Piccini; Xiaoxi Yao
Journal:  Heart Rhythm       Date:  2020-03-04       Impact factor: 6.343

6.  Reader's Comments: Trends in the Utilization of Left Atrial Appendage Exclusion in the United States.

Authors:  Safi U Khan; Muhammad Zia Khan; Mohamad Alkhouli
Journal:  Am J Cardiol       Date:  2020-04-07       Impact factor: 2.778

7.  Early- and mid-term results of cryoablation of atrial fibrillation concomitant with robotic mitral valve surgery.

Authors:  Murat Kadan; Emre Kubat; Gökhan Erol; Kubilay Karabacak; Furkan Burak Akyol; Vedat Yıldırım; Cengiz Bolcal; Ufuk Demirkılıç
Journal:  Anatol J Cardiol       Date:  2021-04       Impact factor: 1.596

Review 8.  Postoperative Atrial Fibrillation Following Cardiac Surgery: From Pathogenesis to Potential Therapies.

Authors:  Yousef Rezaei; Mohammad Mehdi Peighambari; Shayan Naghshbandi; Niloufar Samiei; Alireza Alizadeh Ghavidel; Mohammad Reza Dehghani; Majid Haghjoo; Saeid Hosseini
Journal:  Am J Cardiovasc Drugs       Date:  2020-02       Impact factor: 3.571

9.  Presence of Intracardiac Thrombus at the Time of Left Ventricular Assist Device Implantation Is Associated With an Increased Risk of Stroke and Death.

Authors:  Claudio A Bravo; Justin A Fried; Joshua Z Willey; Azka Javaid; Giulio M Mondellini; Lorenzo Braghieri; Heidi Lumish; Veli K Topkara; Yuji Kaku; Lucas Witer; Hiroo Takayama; Koji Takeda; Gabriel Sayer; Nir Uriel; Ryan T Demmer; Yoshifumi Naka; Melana Yuzefpolskaya; Paolo C Colombo
Journal:  J Card Fail       Date:  2021-06-20       Impact factor: 5.712

10.  Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications.

Authors:  Bryan T Kelly; Viengneesee Thao; Timothy M Dempsey; Lindsey R Sangaralingham; Stephanie R Payne; Taylor T Teague; Teng Moua; Nilay D Shah; Andrew H Limper
Journal:  BMC Pulm Med       Date:  2021-07-17       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.